Similarly, another study has revealed that, in NSCLC, ALKBH5 modulates YTHDF-mediated YAP expression by removing m6A modifications on YAP, and inhibits YAP activity through the miR107/lats2 axis, thus suppressing tumor growth and metastasis70. The gene discussed is ALKBH5; the disease is neoplasm.